Mutagen sensitivity as a predictor of tumor recurrence in patients with cancer of the upper aerodigestive tract

J Natl Cancer Inst. 1998 Feb 4;90(3):243-5. doi: 10.1093/jnci/90.3.243.
No abstract available

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Aged
  • Antimetabolites, Antineoplastic / pharmacology*
  • Bleomycin / pharmacology*
  • Carcinoma, Squamous Cell / drug therapy*
  • Carcinoma, Squamous Cell / genetics*
  • Clinical Trials, Phase III as Topic
  • Female
  • Head and Neck Neoplasms / drug therapy*
  • Head and Neck Neoplasms / genetics*
  • Humans
  • Isotretinoin / pharmacology
  • Male
  • Middle Aged
  • Multicenter Studies as Topic
  • Mutagens / pharmacology*
  • Proportional Hazards Models
  • Randomized Controlled Trials as Topic
  • Risk Factors
  • Teratogens / pharmacology
  • Treatment Failure

Substances

  • Antimetabolites, Antineoplastic
  • Mutagens
  • Teratogens
  • Bleomycin
  • Isotretinoin